malondialdehyde has been researched along with n-adamantyl-4-methylthiazol-2-amine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SW; Dal Nam, K; Hahn, HG; Je Lee, W; Kim, EA; Yang, SJ; Young Choi, S | 1 |
| Ahn, JY; Cho, CH; Cho, SW; Hahn, HG; Kim, J | 1 |
2 other study(ies) available for malondialdehyde and n-adamantyl-4-methylthiazol-2-amine
| Article | Year |
|---|---|
Effects of N-adamantyl-4-methylthiazol-2-amine on hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats.
Topics: Adamantane; Animals; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Glutathione; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Interleukin-1beta; Lipid Metabolism; Lipid Peroxidation; Liver; Male; Malondialdehyde; NF-kappa B; Nitric Oxide; Oxidative Stress; Rats, Sprague-Dawley; Superoxide Dismutase; Thiazoles; Tumor Necrosis Factor-alpha; Vitamin E | 2014 |
N-adamantyl-4-methylthiazol-2-amine suppresses lipopolysaccharide-induced brain inflammation by regulating NF-κB signaling in mice.
Topics: Adamantane; Analysis of Variance; Animals; Anti-Inflammatory Agents; Brain; Brain-Derived Neurotrophic Factor; Cyclooxygenase 1; Cyclooxygenase 2; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Encephalitis; Female; Gene Expression Regulation; Interleukin-1beta; Lipopolysaccharides; Malondialdehyde; Membrane Proteins; Mice; Mice, Inbred C57BL; Nitric Oxide; Prostaglandins E; Superoxide Dismutase; Thiazoles; Tumor Necrosis Factor-alpha | 2015 |